For immediate release
April 27, 2023
The University of Texas System Board of Trustees has unanimously decided to nominate Jochen Reiser, MD, PhD as the sole finalist to become the next president of the University of Texas Medical School at Galveston. Reiser is currently the Chief of Internal Medicine at Rush University Medical Center, and he is Ralph C. Brown, M.D., Professor of Medicine at Rush University in Chicago.
Reiser is a world-renowned research leader in the field of kidney disease, with a strong focus on molecular biology and genetics. He directs an NIH-funded laboratory focused on discovering the causes of kidney disease and developing new treatments to combat kidney disease. Reiser has published his 200 research papers on this topic.
Prior to joining Rush in 2012, Reiser was Professor of Medicine, Anatomy, and Cell Biology, Vice Chair of Research for the School of Medicine, and Chief of the Division of Nephrology and Hypertension at the Leonard M. Miller College of Medicine at the University of Miami. I was. He also served as interim chairman of the Miami School of Medicine.
Reiser graduated from Ruprecht-Karls University in Heidelberg, Germany and completed a residency in internal medicine at the Albert Einstein College of Medicine in New York. He completed fellowships in Nephrology at Massachusetts General Hospital and Brigham and Women’s Hospital at Harvard Medical School. He then served as an assistant professor at Harvard Medical School and was the founding director of the glomerular disease program at Mass General.
Reiser’s candidacy was recommended to the Board by the Presidential Election Advisory Committee chaired by Vice President for Health Affairs John Zarwas. The selection committee included representatives of UTMB faculty, students, alumni, community he leaders, and UT presidents and trustees.
UT Board President Kevin P. Eltife said: “We are grateful for the thoughtful work of the Search Advisory Board and UT Systems leadership.
The UT Medical Branch opened under unified leadership in 1891 as the first public medical school and hospital in the United States. What began as his single hospital and medical school building in Galveston is now a major academic health science center with global impact. UTMB is a member of Texas Medical Center, the world’s largest medical center.
“UTMB is recognized for all three pillars of a world-class academic medical institution: teaching, research and clinical care,” said James B. Milliken, Chancellor of the UT System. “We are delighted that interest in the UTMB presidency has been expressed by potential candidates from across the country. We are pleased to have unanimously endorsed his candidacy.”
As UTMB’s Chief Executive Officer, Reiser will lead the teaching, research and clinical missions of a comprehensive academic health center of nearly 4,000 students and 1,000 faculty members. The center includes medical schools, nursing schools, health professions, public health and public health, and biomedical schools. ; four institutions for advanced research; major medical libraries; world-renowned research companies; A network of hospitals and clinics offering a wide range of primary and specialty care. and numerous research facilities and centers.
By state law, the UT Regent must now wait 21 days before formally appointing Reiser President. If approved, he will succeed Charles P. Mouton, MD, MS, MBA, who will serve as Interim President of the UTMB from August 2022.